131 related articles for article (PubMed ID: 31857716)
1. Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma.
Simpson AD; Soo YWJ; Rieunier G; Aleksic T; Ansorge O; Jones C; Macaulay VM
Br J Cancer; 2020 Mar; 122(5):624-629. PubMed ID: 31857716
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A
J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996
[TBL] [Abstract][Full Text] [Related]
3. Type 1 IGF Receptor Localization in Paediatric Gliomas: Significant Association with WHO Grading and Clinical Outcome.
Clément F; Martin A; Venara M; de Luján Calcagno M; Mathó C; Maglio S; Lombardi MG; Bergadá I; Pennisi PA
Horm Cancer; 2018 Jun; 9(3):205-214. PubMed ID: 29524179
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
[TBL] [Abstract][Full Text] [Related]
5. Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
Bayin NS; Ma L; Thomas C; Baitalmal R; Sure A; Fansiwala K; Bustoros M; Golfinos JG; Pacione D; Snuderl M; Zagzag D; Barcellos-Hoff MH; Placantonakis D
Neoplasia; 2016 Dec; 18(12):795-805. PubMed ID: 27978994
[TBL] [Abstract][Full Text] [Related]
6. IRS2 copy number gain, KRAS and BRAF mutation status as predictive biomarkers for response to the IGF-1R/IR inhibitor BMS-754807 in colorectal cancer cell lines.
Huang F; Chang H; Greer A; Hillerman S; Reeves KA; Hurlburt W; Cogswell J; Patel D; Qi Z; Fairchild C; Ryseck RP; Wong TW; Finckenstein FG; Jackson J; Carboni JM
Mol Cancer Ther; 2015 Feb; 14(2):620-30. PubMed ID: 25527633
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R.
Yang HA; Wang X; Ding F; Pang Q
Med Sci Monit; 2015 Dec; 21():3880-6. PubMed ID: 26656446
[TBL] [Abstract][Full Text] [Related]
8. IGF-1R depletion sensitizes colon cancer cell lines to radiotherapy.
Zong R; Chen X; Feng J; Xu S
Cancer Biomark; 2021; 32(2):199-206. PubMed ID: 34092618
[TBL] [Abstract][Full Text] [Related]
9. IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.
Chitnis MM; Lodhia KA; Aleksic T; Gao S; Protheroe AS; Macaulay VM
Oncogene; 2014 Nov; 33(45):5262-73. PubMed ID: 24186206
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H
Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701
[TBL] [Abstract][Full Text] [Related]
11. The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.
Alexandru O; Purcaru SO; Tataranu LG; Lucan L; Castro J; Folcuţi C; Artene SA; Tuţă C; Dricu A
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29329222
[TBL] [Abstract][Full Text] [Related]
12. GSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo.
Zhou X; Shen F; Ma P; Hui H; Pei S; Chen M; Wang Z; Zhou W; Jin B
Mol Med Rep; 2015 Oct; 12(4):5641-6. PubMed ID: 26238593
[TBL] [Abstract][Full Text] [Related]
13. Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival.
Chen YM; Leibovitch M; Zeinieh M; Jabado N; Brodt P
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259440
[TBL] [Abstract][Full Text] [Related]
14. Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways.
Dayyani F; Parikh NU; Varkaris AS; Song JH; Moorthy S; Chatterji T; Maity SN; Wolfe AR; Carboni JM; Gottardis MM; Logothetis CJ; Gallick GE
PLoS One; 2012; 7(12):e51189. PubMed ID: 23300537
[TBL] [Abstract][Full Text] [Related]
15. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.
Qureishi A; Rieunier G; Shah KA; Aleksic T; Winter SC; Møller H; Macaulay VM
Clin Otolaryngol; 2019 Nov; 44(6):1026-1036. PubMed ID: 31536667
[TBL] [Abstract][Full Text] [Related]
16. IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.
Wan X; Yeung C; Heske C; Mendoza A; Helman LJ
Neoplasia; 2015 Apr; 17(4):358-66. PubMed ID: 25925378
[TBL] [Abstract][Full Text] [Related]
17. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
[TBL] [Abstract][Full Text] [Related]
18. Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.
Hou X; Huang F; Macedo LF; Harrington SC; Reeves KA; Greer A; Finckenstein FG; Brodie A; Gottardis MM; Carboni JM; Haluska P
Cancer Res; 2011 Dec; 71(24):7597-607. PubMed ID: 22042792
[TBL] [Abstract][Full Text] [Related]
19. Co-inhibition of epidermal growth factor receptor and type 1 insulin-like growth factor receptor synergistically sensitizes human malignant glioma cells to CD95L-induced apoptosis.
Steinbach JP; Eisenmann C; Klumpp A; Weller M
Biochem Biophys Res Commun; 2004 Aug; 321(3):524-30. PubMed ID: 15358139
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
